196 related articles for article (PubMed ID: 21945434)
21. CLAC binds to amyloid beta peptides through the positively charged amino acid cluster within the collagenous domain 1 and inhibits formation of amyloid fibrils.
Osada Y; Hashimoto T; Nishimura A; Matsuo Y; Wakabayashi T; Iwatsubo T
J Biol Chem; 2005 Mar; 280(9):8596-605. PubMed ID: 15615705
[TBL] [Abstract][Full Text] [Related]
22. Fibrillar seeds alleviate amyloid-β cytotoxicity by omitting formation of higher-molecular-weight oligomers.
Wu WH; Liu Q; Sun X; Yu JS; Zhao DS; Yu YP; Luo JJ; Hu J; Yu ZW; Zhao YF; Li YM
Biochem Biophys Res Commun; 2013 Sep; 439(3):321-6. PubMed ID: 24012671
[TBL] [Abstract][Full Text] [Related]
23. Non-esterified fatty acids generate distinct low-molecular weight amyloid-β (Aβ42) oligomers along pathway different from fibril formation.
Kumar A; Bullard RL; Patel P; Paslay LC; Singh D; Bienkiewicz EA; Morgan SE; Rangachari V
PLoS One; 2011 Apr; 6(4):e18759. PubMed ID: 21526230
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of Alzheimer's amyloid-beta aggregation in-vitro by carbenoxolone: Insight into mechanism of action.
Sharma S; Nehru B; Saini A
Neurochem Int; 2017 Sep; 108():481-493. PubMed ID: 28652220
[TBL] [Abstract][Full Text] [Related]
25. Amyloid-like fibril formation by tachykinin neuropeptides and its relevance to amyloid β-protein aggregation and toxicity.
Singh PK; Maji SK
Cell Biochem Biophys; 2012 Sep; 64(1):29-44. PubMed ID: 22628076
[TBL] [Abstract][Full Text] [Related]
26. High ability of apolipoprotein E4 to stabilize amyloid-β peptide oligomers, the pathological entities responsible for Alzheimer's disease.
Cerf E; Gustot A; Goormaghtigh E; Ruysschaert JM; Raussens V
FASEB J; 2011 May; 25(5):1585-95. PubMed ID: 21266538
[TBL] [Abstract][Full Text] [Related]
27. Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Abeta oligomerization.
De Felice FG; Vieira MN; Saraiva LM; Figueroa-Villar JD; Garcia-Abreu J; Liu R; Chang L; Klein WL; Ferreira ST
FASEB J; 2004 Sep; 18(12):1366-72. PubMed ID: 15333579
[TBL] [Abstract][Full Text] [Related]
28. Nonphosphorylated tau slows down Aβ
Beeg M; Battocchio E; De Luigi A; Colombo L; Natale C; Cagnotto A; Corbelli A; Fiordaliso F; Diomede L; Salmona M; Gobbi M
J Biol Chem; 2021; 296():100664. PubMed ID: 33865852
[TBL] [Abstract][Full Text] [Related]
29. A chemical screening approach reveals that indole fluorescence is quenched by pre-fibrillar but not fibrillar amyloid-beta.
Reinke AA; Seh HY; Gestwicki JE
Bioorg Med Chem Lett; 2009 Sep; 19(17):4952-7. PubMed ID: 19640715
[TBL] [Abstract][Full Text] [Related]
30. Formation of non-toxic Aβ fibrils by small heat shock protein under heat-stress conditions.
Sakono M; Utsumi A; Zako T; Abe T; Yohda M; Maeda M
Biochem Biophys Res Commun; 2013 Jan; 430(4):1259-64. PubMed ID: 23261462
[TBL] [Abstract][Full Text] [Related]
31. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
Savelieff MG; DeToma AS; Derrick JS; Lim MH
Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056
[TBL] [Abstract][Full Text] [Related]
32. Walnut extract inhibits the fibrillization of amyloid beta-protein, and also defibrillizes its preformed fibrils.
Chauhan N; Wang KC; Wegiel J; Malik MN
Curr Alzheimer Res; 2004 Aug; 1(3):183-8. PubMed ID: 15975066
[TBL] [Abstract][Full Text] [Related]
33. Effects of peptides derived from terminal modifications of the aβ central hydrophobic core on aβ fibrillization.
Bett CK; Serem WK; Fontenot KR; Hammer RP; Garno JC
ACS Chem Neurosci; 2010 Oct; 1(10):661-78. PubMed ID: 22778807
[TBL] [Abstract][Full Text] [Related]
34. A beta-amino acid modified heptapeptide containing a designed recognition element disrupts fibrillization of the amyloid beta-peptide.
Castelletto V; Hamley IW; Lim T; De Tullio MB; Castaño EM
J Pept Sci; 2010 Sep; 16(9):443-50. PubMed ID: 20648477
[TBL] [Abstract][Full Text] [Related]
35. A strategy for designing a peptide probe for detection of β-amyloid oligomers.
Hu Y; Su B; Kim CS; Hernandez M; Rostagno A; Ghiso J; Kim JR
Chembiochem; 2010 Nov; 11(17):2409-18. PubMed ID: 21031399
[TBL] [Abstract][Full Text] [Related]
36. Destabilization of β-amyloid aggregates by thrombin derived peptide: plausible role of thrombin in neuroprotection.
De D; Bhattacharjee P; Das H; Kumar KS; Biswas SC; Bhattacharyya D
FEBS J; 2020 Jun; 287(11):2386-2413. PubMed ID: 31747135
[TBL] [Abstract][Full Text] [Related]
37. Biflavonoid-Induced Disruption of Hydrogen Bonds Leads to Amyloid-β Disaggregation.
Windsor PK; Plassmeyer SP; Mattock DS; Bradfield JC; Choi EY; Miller BR; Han BH
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809196
[TBL] [Abstract][Full Text] [Related]
38. Peptide dimer structure in an Aβ(1-42) fibril visualized with cryo-EM.
Schmidt M; Rohou A; Lasker K; Yadav JK; Schiene-Fischer C; Fändrich M; Grigorieff N
Proc Natl Acad Sci U S A; 2015 Sep; 112(38):11858-63. PubMed ID: 26351699
[TBL] [Abstract][Full Text] [Related]
39. Elucidating the Structures of Amyloid Oligomers with Macrocyclic β-Hairpin Peptides: Insights into Alzheimer's Disease and Other Amyloid Diseases.
Kreutzer AG; Nowick JS
Acc Chem Res; 2018 Mar; 51(3):706-718. PubMed ID: 29508987
[TBL] [Abstract][Full Text] [Related]
40. The effect of tachykinin neuropeptides on amyloid β aggregation.
Flashner E; Raviv U; Friedler A
Biochem Biophys Res Commun; 2011 Apr; 407(1):13-7. PubMed ID: 21352807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
